Regeneron-1787 for Cutaneous Squamous Cell Carcinoma - Clinical Trial
What is the Purpose of this Study?
Who Can Participate in the Study?
Adults with Squamous Cell Carcinoma that keeps coming back.
-The lesion must be about a half inch to one inch across
What is Involved?
If you choose to be in this study, you will:
-Get injected with the study drug (Cemiplimab) for 12 weeks
-Have a Blood draw
-Get a small biopsy of the skin
-Have an x-ray of your chest
-Give a urine sample